申请人:Stiefel Laboratories, Inc.
公开号:US04393061A1
公开(公告)日:1983-07-12
N-[3-(4-3-Fluorobenzyloxy}phenoxy)propyl]morpholine and its pharmaceutically acceptable salts possess topical anesthetic-antipruritic properties. The free base can be obtained by coupling an alkali metal salt of 4-(3-fluorobenzyloxy)phenol and N-(3-chloropropyl)morpholine.
N-[3-(4-3-氟苯甲氧基}苯氧基)丙基]吗啡啶和其药学上可接受的盐具有局部麻醉 - 止痒特性。可以通过将4-(3-氟苯甲氧基)苯酚的碱金属盐与N-(3-氯丙基)吗啡啶偶联来获得游离碱。